Examination Report |
1 | TM-5 | 14 Jan 2013 |
10 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 23 Jul 2021 |
11 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 25 Jan 2022 |
12 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 29 Jul 2022 |
13 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 17 Jan 2023 |
14 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 22 May 2023 |
15 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 01 Mar 2024 |
16 | TM-1 | |
16 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 07 Oct 2024 |
17 | TM-1 | |
2 | Opponents Affidavit Rule | 02 Dec 2013 |
3 | TM-16 | 08 Feb 2017 |
4 | Letters related to TOP | 14 Jun 2019 |
5 | Letters related to TOP | 13 Dec 2019 |
6 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 01 Jan 2020 |
7 | Letters related to TOP | 02 Jan 2020 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 26 Jun 2020 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 26 Jan 2021 |
As per IP India data the trademark was applied on 23 September 2011.
ABBOTT HEALTHCARE applied for Ertycin l.
Listed class of trademark Ertycin l is 5.
Ertycin l is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 2209915
Trademark application was filed by the following attorney agent:
Zeusip
The trademark is categorized as DEVICE.